160 Participants Needed

Brain Stimulation for Speech Learning

DO
Overseen ByDavid Ostry
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores how the brain learns and remembers speech using transcranial magnetic stimulation (TMS). Researchers focus on the roles of different brain areas, such as those for hearing, touch, and movement, in learning and retaining speech skills. Participants will undergo brain stimulation, specifically with continuous theta-burst stimulation (cTBS), while performing speech tasks to assess its impact on their ability to learn and remember. This trial may suit right-handed, fluent English speakers with normal hearing and no speech or reading issues. As an unphased trial, it offers a unique opportunity to contribute to groundbreaking research on brain function and speech learning.

Will I have to stop taking my current medications?

The trial excludes participants who are taking psychoactive medications, so you would need to stop taking those to participate. For other medications, the protocol does not specify.

What prior data suggests that this brain stimulation technique is safe for speech learning?

Research has shown that continuous theta-burst stimulation (cTBS) is generally safe. Studies have found that cTBS, used to treat conditions like auditory hallucinations in schizophrenia and tinnitus, does not cause major side effects. For example, one study found that applying cTBS to brain areas involved in hearing and speech was safe and did not impair these functions.

In another study on learning to speak, cTBS was used without any serious side effects. Overall, these findings suggest that cTBS is a safe option for similar research. However, as with any treatment, individual experiences may vary, so discussing any concerns with the study staff or a healthcare provider is important.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores how continuous theta-burst stimulation (cTBS) can enhance speech learning by targeting specific brain regions. Unlike traditional speech therapy that focuses on exercises and practice over time, cTBS offers a unique approach by directly stimulating the auditory, somatosensory, or motor cortex. This method could accelerate learning and retention by directly influencing brain activity patterns. The trial aims to uncover how these targeted stimulations improve speech learning, potentially offering a more efficient and effective way to address speech disorders.

What evidence suggests that this trial's treatments could be effective for speech learning?

Studies have shown that continuous theta-burst stimulation (cTBS) can improve speech and sound comprehension. Research indicates that applying cTBS to certain brain areas can significantly enhance speech understanding and conditions like aphasia, which affects speaking and comprehension. Additionally, cTBS is considered safe for hearing and speech perception. In this trial, participants will receive cTBS applied to different brain areas, such as the auditory, somatosensory, or motor cortex, with either altered or unaltered auditory feedback. This approach suggests that targeting specific brain areas with cTBS might aid in learning and remembering new speech patterns. Overall, early findings are promising for using cTBS in learning and retaining speech skills.25678

Who Is on the Research Team?

DO

David Ostry

Principal Investigator

Yale University

Are You a Good Fit for This Trial?

This trial is for right-handed, fluent English speakers with normal hearing and no speech disorders or reading disabilities. It's not suitable for individuals with a cardiac pacemaker, cochlear implant, tinnitus, metal implants in the brain or body, history of epilepsy or severe head injuries, those who are pregnant or on psychoactive medications.

Inclusion Criteria

Right-handed
No speech disorder or reading disability
I have normal hearing.

Exclusion Criteria

Pregnancy
Cardiac pacemaker
Aneurysm clip
See 9 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Participants perform learning tasks with altered or unaltered auditory feedback, followed by cTBS to specific brain regions. This is repeated on day 2.

2 days
2 visits (in-person)

Retention Assessment

Participants return 24 hours after treatment to assess retention of learning.

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

1-2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Adaptation
  • continuous theta-burst stimulation (cTBS)
Trial Overview The study tests how learning and retaining new ways to speak might change the brain. Participants will undergo continuous theta-burst stimulation (cTBS) to disrupt brain activity and adaptation exercises while their brain function is monitored using fMRI scans and sensory/motor evoked potentials.
How Is the Trial Designed?
8Treatment groups
Experimental Treatment
Group I: Unaltered auditory feedback + cTBS to somatosensory cortexExperimental Treatment2 Interventions
Group II: Unaltered auditory feedback + cTBS to motor cortex control zoneExperimental Treatment2 Interventions
Group III: Unaltered auditory feedback + cTBS to motor cortexExperimental Treatment2 Interventions
Group IV: Unaltered auditory feedback + cTBS to auditory cortexExperimental Treatment2 Interventions
Group V: Altered auditory feedback + cTBS to somatosensory cortexExperimental Treatment2 Interventions
Group VI: Altered auditory feedback + cTBS to motor cortex control zoneExperimental Treatment2 Interventions
Group VII: Altered auditory feedback + cTBS to motor cortexExperimental Treatment2 Interventions
Group VIII: Altered auditory feedback + cTBS to auditory cortexExperimental Treatment2 Interventions

Find a Clinic Near You

Who Is Running the Clinical Trial?

Yale University

Lead Sponsor

Trials
1,963
Recruited
3,046,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Published Research Related to This Trial

Continuous theta burst stimulation (cTBS) effectively inhibits synaptic transmission in the primary motor cortex for up to 1 hour, demonstrating its potential as a novel neuromodulation technique.
cTBS applied to the left motor cortex increases local GABA levels, indicating enhanced GABAergic activity, while not significantly affecting glutamate/glutamine levels, suggesting a specific mechanism of action for this stimulation technique.
Neurochemical effects of theta burst stimulation as assessed by magnetic resonance spectroscopy.Stagg, CJ., Wylezinska, M., Matthews, PM., et al.[2022]
Continuous theta burst stimulation (cTBS) can effectively induce temporary impairments in semantic processing, similar to traditional 1 Hz repetitive transcranial magnetic stimulation (rTMS), as shown in a study with 80 subjects across five groups.
cTBS at 90% active motor threshold resulted in a significant increase in reaction times during a lexical decision task, indicating its efficacy in creating 'virtual lesions' in the left superior temporal cortex, while also being faster and more comfortable for participants compared to 1 Hz rTMS.
Comparing the after-effects of continuous theta burst stimulation and conventional 1 Hz rTMS on semantic processing.Brรผckner, S., Kiefer, M., Kammer, T.[2013]
Intermittent theta burst stimulation (iTBS) applied to the left frontal lobe showed significant improvements in language abilities for participants with post-stroke aphasia, as evidenced by moderate to large effect sizes on tests like the Boston Naming Test and Semantic Fluency Test.
The study, involving 36 participants over 3 weeks, demonstrated that iTBS not only enhanced language function but also led to increased brain activation and connectivity, suggesting that this treatment may promote cortical plasticity in the brain.
Intermittent Theta Burst Stimulation (iTBS) for Treatment of Chronic Post-Stroke Aphasia: Results of a Pilot Randomized, Double-Blind, Sham-Controlled Trial.Szaflarski, JP., Nenert, R., Allendorfer, JB., et al.[2021]

Citations

Continuous theta burst stimulation over right cerebellum for ...The primary outcome measures are voice/speech quality and neurobehavioral parameters of auditory-vocal integration. The secondary outcome measures are cognitive ...
Hearing Safety of Long-Term Treatment with Theta Burst ...Theta burst stimulation of the temporal and temporoparietal cortex appears to be safe with respect to hearing and speech perception. These data provide evidence ...
Advances in theta-burst transcranial magnetic stimulation for ...The results showed that the cTBS group showed significantly greater improvement in auditory comprehension and aphasia after 3 weeks of ...
NCT04818268 | Sensory Memory in Speech Motor LearningThe proposed studies focus on memory for speech movements and sounds and its relation to learning. Continuous theta-burst transcranial magnetic stimulation ( ...
Assessing the Effects of Continuous Theta Burst ...We conclude that continuous theta burst stimulation over the dorsolateral prefrontal cortex mainly inhibits cognitive performance.
The efficacy and safety of continuous theta burst ...This meta-analysis focused on randomized controlled clinical trials (RCTs) to assess the efficacy of adjuvant cTBS on auditory hallucinations in schizophrenia.
Efficacy and safety of bilateral continuous theta burst ...We hypothesize that compared to sham stimulation cTBS can induce a distinctive attenuation of tinnitus distress and loudness and thus be of therapeutic value.
Speech Motor Learning and Retention (Master Protocol) | ...Continuous theta-burst stimulation (cTBS) is delivered following adaptation to altered auditory feedback to assess its effects on the retention of new learning.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity